OmniaBio
Shaunelle V. is a professional with a strong background in biomedical science, biochemistry, and biology. Shaunelle has held various roles in quality assurance, compliance transformation, and laboratory management. With experience in teaching, research project guidance, and quality improvement consulting, Shaunelle brings a diverse skill set to their current position as Manager GMP Compliance Transformation at OmniaBio.
This person is not in any teams
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.